NEWSLETTER SIGNUP

CONNECT WITH NJTV

  • DONATE

NJ Spotlight News | Clip | Johnson & Johnson vaccine on track for February FDA approval

New Brunswick-based Johnson & Johnson is on track to seek approval for its one-dose COVID-19 vaccine early next month. The vaccine is currently in late-stage trials, with important safety data coming by the end of the month. Johnson & Johnson has set a goal of providing 1 billion doses this year.

0:02:35 | AIRED: 1/11/2021 |
Membership Promo
Membership Promo